Picture of 23andMe Holding Co. logo

ME 23andMe Holding Co. Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for 23andMe Holding Co., fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-184-251-184-217-312
Depreciation
Amortisation
Non-Cash Items37.578.187.625126
Unusual Items
Other Non-Cash Items
Changes in Working Capital38-36.21.51-0.515-16.4
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-98.1-186-74.3-167-165
Capital Expenditures-27.8-73.6-7.37-14-11.3
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items00.7650.838-94.20.005
Acquisition of Business
Sale of Fixed Assets
Cash from Investing Activities-27.8-72.8-6.54-108-11.3
Financing Cash Flow Items-0.3940-3.32-30.6-0.89
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities3448.831555469.78
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash218-25074.5271-167